Acute myeloid leukemia, in relapse
Clinical trials for Acute myeloid leukemia, in relapse explained in plain language.
Never miss a new study
Get alerted when new Acute myeloid leukemia, in relapse trials appear
Sign up with your email to follow new studies for Acute myeloid leukemia, in relapse, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Two-Drug attack outsmart resistant leukemia?
Disease control OngoingThis early-stage trial is testing whether adding an experimental drug called iadademstat to the approved leukemia drug gilteritinib can help people with a specific type of acute myeloid leukemia (AML) that has returned or not responded to treatment. The study focuses on patients …
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase 1 • Sponsor: Oryzon Genomics S.A. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug cocktail offers hope for kids with relapsed leukemia
Disease control OngoingThis study tests two drugs, selinexor and venetoclax, given together with standard chemotherapy for children and young adults whose acute myeloid leukemia (AML) has returned or not responded to treatment. The main goal is to find the safest dose and see how well the combination w…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase 1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC